22 May 2001: Corrections made to redacted text restorations.
21 May 2001
Source: Digital images from IntellNet.
Original 72 TIFF images of MKULTRA Subproject 35 documents, Zipped: http://cryptome.org/mkultra-035.zip (5.2MB). Only 19 of the images are transcribed here.
xxxxx indicates redactions. [Text] indicates redacted text restored as derived from related documents:
Senate hearing on MKULTRA, August, 1977:http://www.parascope.com/ds/documentslibrary/documents/mkultrahearing/index.htm
From Marks' book, Chapter 12, Note 6:
6. Geschickter was an extremely important TSS asset with connections in high places. In 1955 he convinced Agency officials to contribute $375,000 in secret funds toward the construction of a new research building at Georgetown University Hospital. (Since this money seemed to be coming from private sources, unwitting Federal bureaucrats doubled it under the matching grant program for hospital construction.) The Agency men had a clear understanding with Geschickter that in return for their contribution, he would make sure they received use of one-sixth of the beds and total space in the facility for their own "hospital safehouse." They then would have a ready source of "human patients and volunteers for experimental use," according to a CIA document, and the research program in the building would provide cover for up to three TSS staff members. Allen Dulles personally approved the contribution and then, to make sure, he took it to President Eisenhower's special committee to review covert operations. The committee also gave its assent, with the understanding that Geschickter could provide "a reasonable expectation" that the Agency would indeed have use of the space he promised. He obviously did, because the CIA money was forthcoming. (This, incidentally, was the only time in a whole quarter-century of Agency behavior-control activities when the documents show that CIA officials went to the White House for approval of anything. The Church committee found no evidence that either the executive branch or Congress was informed of the programs.)
[2 pages.]
35-17
SECRET
20 October 1954
MEMORANDUM FOR: DIRECTOR, CENTRAL INTELLIGENCE
FROM: Deputy Director (Plans)
SUBJECT: Letter to the Chairman of the [Atomic Energy Commission] prepared for your Signature
1. Attached herewith is a letter to the Chairman of the [Atomic Energy Commission] which has been prepared for your signature and which indicates the Agency is interested in the construction of the new research wing to [Georgetown University] Hospital.
2. The Agency will make use of the new research wing in connection with research problems in the defense against drugs and chemical techniques used in interrogations and brainwashing.
3. The [Georgetown University] Hospital will be completely unwitting of our interest in them. The work which will be done in the facility will be handled through a cut-out which will conceal Agency sponsorship.
Original signed by
xxxxxxxxxxxxxxxxxx
Chief, DD/P/TSS
Attachment:
Letter for Signature of DCI
TSS/OC xxxxxxxx (20 October 1954)
Distribution:
Addressee: Orig. & w w/attachment
TSS/CD - 1 w/attachment
TSS/OC - 1 w/attachment
SECRET
35-17
1-2961
SECRET
6-1837
The Honorable xxxxxxxxxx
Chairman
[Atomic Energy Commission]
xxxxxxxxxxxxxxxx
Dear Mr. xxxxxxxxxxx
The Central Intelligence Agency is greatly interested in the vital problem of defense against drugs and chemical techniques used in interrogation and "brainwashing".
The new projected research wing to the [Georgetown University] Hospital which we discussed recently will significantly and specifically add to our research potential in solving this problem.
I understand that you have been asked to provide financial support for equipping this research installation by virtue of the fact that it proposes to investigate the chemotherapy of chronic diseases using radioisotope techniques.
To the extent that it may influence whatever decision you might make to support this project, I would like to express this Agency's conviction that it will specifically aid us toward the solution of a group of difficult and important problems.
Security considerations require that research of interest to this Agency at the new facility be so conducted that the Hospital remain completely unaware of our sponsorship. It will therefore be very much appreciated if our interest in this matter be withheld from the Hospital authorities.
Sincerely,
[No signature]
Allen W. Dulles
Director
TSS/OC xxxxxxxx (20 October 1954)
Distribution:
Addressee - Orig. & 1
Signer - 2
[Illegible] - 1 (yellow)
35-19
TOP SECRET
Copy # 2 of 2 copies
T. S. 101077
15 November 1954
MEMORANDUM FOR: DIRECTOR, CENTRAL INTELLIGENCE
VIA: Deputy Director (Plans)
SUBJECT: Project MKULTRA, Subproject 35
1. This project concerns cover for the DD/P/TSS biological and chemical warfare
program and involves expenditure of $125,000 by CIA and the resultant expenditure
of an additional equal amount of matching funds by another element of the
Government. In the opinion of the undersigned this total investment of $250,000
is fully justified because of benefits to the Agency outlined in Tab A.
2. Tab A describes a proposed arrangement whereby the Agency would make a single non-recurring grant of $125,000 to the [Georgetown University] Hospital for the construction of a new research wing using the [Geschickter Fund] as cut-out. Agency-sponsored research projects in these sensitive fields would be carried out in the new wing, and Agency employees would be able to participate in the work without the University being aware of CIA interest. Each project would be separately funded under existing procedures using the [Geschickter Fund] as cut-out.
3. The [Georgetown University] Hospital will not be aware of Agency participation in either the building fund or future research projects. This Agency is also encouraging the [Atomic Energy Commission] to make a contribution of $500,000 to the same construction fund. The Hospital will be aware of the xxxxx donation but not of our encouragement.
4. Project MKULTRA, as previously approved by the DCI, sets up controls and procedures under which TSS spends a percentage of its annual Research and Development budget for highly sensitive projects in certain fields, including covert biological, chemical and radiological warfare. The establishment of the cover to be provided by Subproject 35 was not in mind when Project MKULTRA was originally approved, and permission is therefore now requested to use it for this purpose. No new funds are required, and all existing MKULTRA controls and audit procedure remain unchanged. Tab B attached is a memorandum to the DD/A for your signature authorizing this procedure should it receive your approval.
Original signed by
xxxxxxxxxxxxxxxxxxx
Chief, DD/P/TSS
Attachments: (2)
Tab A - Outline of Plan (T.S. 10177A)
Tab B - Suggested Memorandum to DD/A for signature (T.S. 101077B)
APPROVED:
/s/ Richard Helms
Date: 16 Nov. '54
Deputy Director (Plans)
Concur C P Cabell DDCI 8 Jan 55
APPROVED:
*Signed
Date: JAN 15 1955
Director, Central Intelligence
Distribution:
Copy # 1 w/attachments A and B - DCI (for approval; then return to TSS/OC)
Copy # 2 w/attachment A - TSS/CD
* "On understanding that other funds adequate to carry out project are made available from other sources. AWD."
Copy # 2 of 2 copies
TOP SECRET
[8 pages; classification stamp top and bottom all pages.]
TOP SECRET
Copy # 2 of 2 copies
T.S. 10177A
Tab A
SUBPROJECT 35 - PROJECT MKULTRA
For the purpose of establishing a cover organization for highly
sensitive projects in the field of covert Biological, Chemical
and Radiological Warfare
_________________________________________________
I. Background of Project MKULTRA.
In 1953 the DCI approved Project MKULTRA which established procedures and controls under which research projects in certain highly sensitive fields could be carried out by TSS without the necessity of signing the usual contracts. The approved procedures apply to xx of the annual over-all Research and Development budget, and no additional funds are required. Controls established in the Project Review Committee approval of the Research and Development program (other than the signing of a contract) remain unchanged, and special provisions for audit are included. All files are retained by TSS.
These controls and procedures were approved since it is highly undesirable from a policy and security point of view that contracts be signed indication Agency or Government interest in this field of endeavor. In a great many instances the work must be conducted by individuals who are not and should not be aware of Agency interest. In other cases the individuals involved are unwilling to have their names on a contract which remains out of their control in our files. Experience has shown that qualified, competent individuals in the fields of physiological, psychiatric and other biological sciences are very reluctant to enter into signed agreements of any sort which would connect the with this activity since such connection might seriously jeopardize their professional reputations.
When Project MKULTRA was approved, it was not contemplated that it would be used for the establishment of cover. Over forty individual research and development projects have been established under this framework and have been carried out extremely successfully, both from technical and administrative points of view. The experience gained in handling these projects has emphasized that establishment of better cover both for projects and for associated Agency scientists is of utmost importance. Subproject 35 would establish such cover.
II. Background of the [Geschickter Fund for Medical Research].
The [Geschickter Fund for Medical Research] was incorporated in xxxx in the State of xxxxxxxx. It has a Board of Directors of six members, one of whom is Dr. [Charles Geschickter] who acts as Executive Director of the Fund. Since xxx it has solicited funds from various individuals to finance a program of basic research in the chemotherapy of cancer, asthma, hypertension, psychosomatic disorders and other chronic diseases. Since 1951 the Fund has co-operated with the Chemical Division of TSS and acted smoothly and efficiently, both as a cut-out for dealing with contractors in the fields of covert chemical and biological warfare, and as a prime contractor for certain areas of biological research. Projects presently being handled for the Agency by the Fund are administered under the controls and procedures previously approved for MKULTRA.
III. Background of Dr. [Charles Geschickter].
Dr. [Charles Geschickter] is internationally known as a xxxxxxxxxxxx in the field of cancer research and is Professor of xxxxxxxxxxxx at [Georgetown University]. In the past he has been associated in a research capacity with both the xxxxxxxxxxx and the xxxxxxxxxxxxxxx University. During the war Dr. [Geschickter] served as a xxxxxxxxxxxx in the Bureau of Medicine and Surgery in the Navy. Since then he has maintained a consulting relationship to the Navy medical research program. Dr. [Geschickter] is TOP SECRET cleared and witting of Agency sponsorship of the programs carried out by the Fund as are two other members of the Fund's Board of Directors.
IV. [Georgetown University] Hospital Building Fund.
Dr. [Geschickter] as Professor of Pathology at [Georgetown University] has been actively engaged in a campaign to raise funds for the purpose of erecting a new clinical research wing on the existing [Georgetown University] Hospital. The research wind will consist of a building xxxxxxxx high, xxxx long and xxxx wide. xxxxxxxxxxxx of the space will be research laboratories and offices while xxx research beds will occupy the remainder. Dr. [Geschickter]'s participation in the fund-raising campaign outlined below will result in his having control of one-sixth of the total space in addition to the basement and general out-patient facilities. In this effort, Dr. [Geschickter] has secured the enthusiastic support of the medical faculty and the officers of the University who have carried the preliminary arrangements forward to the maximum extent of their resources.
V. Financial Situation.
The University will require about $3,000,000 for the xxxxxxxxx addition. This sum is exclusive of the cost of land and the heating and power supply which are already available at the site. At the present time under Public Law 221, funds are available to match funds raised by the University. The University has allocated $1,000,000 to this project and will assume upkeep and staffing obligations. Dr. [Geschickter] has agreed that if CIA will provide the [Geschickter Fund] a grant of $125,000, the Fund will match this amount and make a total donation of $250,000 to the University Building Fund. This Agency's contribution will be made under the condition that it will be refunded if construction does not take place.
TSS has discussed this situation with Mr. xxxxxxxxxxxxxxxxx, Chairman, [Atomic Energy Commission] and has encouraged the [AEC] to donate $500,000 to the building project on the basis that radiological research will be conducted in the new wing. Mr. xxxxxxxx, though aware of our interest in the building, is unwitting of our specific fields of research and individual projects. In summary, the financial situation would be as follows:
$1,000,000 - Provided by xxxxxxxxxxxxxxxxxxxxxxxxxxx
250,000 - Donation from [Geschickter Fund] ($125,000 supplied by CIA)
1,250,000 - Matched funds from Public Law 221
500,000 - Grant from [AEC]
_________
$3,000,000 - TOTAL
Although it is recognized that the Federal contribution of $1,250,000 under P.L. 221 is seemingly inflated by reason of inclusion of the CIA contribution in that of the [Geschickter Fund], actually the value to the CIA is $250,000 and not just $125,000, the amount of the CIA's contribution; furthermore the inclusion of the CIA contribution in that of the [Geschickter Fund] is the best method of maintaining security.
VI. Difficulties Faced by TSS.
It has been generally recognized for some time that the external research activities of the Chemical Division of TSS in the field of covert biological, chemical and radiological warfare are sorely in need of proper cover. Although Project MKULTRA provides excellent administrative and financial cover for projects, it does not afford cover for scientific or technical personnel. MKULTRA has been used for dealing through the [Geschickter Fund] as cut-out and for working directly with individuals or private companies. The use of the [Geschickter Fund] in the future will be increasingly limited due to:
(a) The increasing number of people who, albeit properly cleared, are aware of the Agency connection with the [Geschickter Fund].
(b) The feeling by xxxxxxxxxxxxxxx that the Agency employees contracting with him (Drs. Gottlieb, xxxxxxxxx, etc.) have no cover of any sort and consequently expose him to unnecessary and highly undesirable personal risk; and
(c) The widespread intra-Agency awareness of the nature of the relationship between the Fund and the Agency.
Another serious problem faced by TSS/CD as a result of lack of suitable cover is the difficulty in planning careers for technical and scientific personnel in the biological field. A long-range career concept of activities in this field inevitably includes proper cover for the individuals concerned. The availability of research facilities at the [Georgetown University] Hospital will offer an excellent opportunity to solve many of the above problems, and Dr. xxxxxxxxxxxxxxx is willing and able to make reasonable arrangements to suit our needs. Up to three Chemical Division employees can be integrated into Dr. xxxxxxxxxxxxxxx's program for work in the new hospital wind on the Agency's research projects. Although career planning was not a consideration when planning the procedures ad controls established by Project MKULTRA, nevertheless this particular subproject, in addition to its primary objective, will be of very great secondary help in simplifying and eliminating many of the very awkward and dangerous conditions facing certain Chemical Division employees.
VII. Advantages and Benefits Accruing to TSS.
The contemplated arrangements will result in many advantages and benefits, including the following:
(a) One-sixth of the total space in the new research wing is to be available to Dr. xxxxxxxxxxxx and in turn, will be available to the Chemical Division of TSS. This will provide laboratory and office space, technical assistants, equipment and experimental animals for use of Chemical Division personnel in connection with specific future projects.
(b) The cost of the Chemical Division projects which are to be carried out under this cover will be covered by funds made available through Project MKULTRA, and projects will be subject to the procedures and controls established for MKULTRA. The funds will be passed through the [Geschickter Fund] as has been done in the past. The Fund in turn will either pay expenses directly or transfer the money to the University for this purpose. Each project will be individually funded based on its particular budget, and there will be no other continuing or recurring charges for items such as space, facilities, etc.
(c) The Agency's sponsorship of sensitive research projects would be completely deniable since no connection would exist between the University and the Agency.
(d) Excellent professional cover would be provided for up to three bio-chemical employees of the Chemical Division of TSS. This would allow open attendance at scientific meetings, the advancement of personal standing in the scientific world, and as such, would constitute a major efficiency and morale booster.
(e) Human patients and volunteers for experimental use will be available under excellent clinical conditions with the full supervision of the [Georgetown University] Hospital.
(f) There would be available the equivalent of a hospital safehouse.
(g) It is expected that the output of useful results of the Chemical Division in the bio-chemical field will be greatly improved through the more efficient use of technical personnel who would be able to spend more of their time on actual laboratory work.
(h) [Two lines redacted.]
(i) Excellent facilities would be provided for recruiting new scientific personnel since members of the Chemical Division working under this cover will be in daily contact with members of the Graduate School of the University.
(j) The regular University library and reprint service will be available as a source of technical information.
VIII. Funding.
It is proposed that $125,000 be granted to the [Geschickter Fund]. If approval is granted, TSS will arrange for payment to be made under the procedures and controls of MKULTRA. These funds would come out of the presently approved TSS Research and Development budget for FY 1955 and no new funds are involved. The funds would be transferred as a grant to the [Geschickter Fund]. In turn the [Geschickter Fund] will match these funds with an equal amount and donate a total of $250,000 to the University as outlined in paragraph V. The sum of $125,000 would be entirely in the nature of a grant and would in due course be merged with the entire $3,000,000 raised for the construction of the wing. The Agency would retain no residual interest in the building or title to any equipment or facilities purchased with this money.
This single grant will constitute the Agency's entire participation in the new hospital wing, and there will be no recurring obligations in the form of annual support of the hospital or additional grants. Transmission of Agency funds to the [Geschickter Fund] will be made through previously established cover channels set up by the [Geschickter Fund] for similar transmittals in the past. The donation on the Fund's books will be shown as having been received from an anonymous trust in xxxxxxxxxxxx.
In the future when TSS sponsors sensitive research projects which are to be carried out in the [Georgetown University] Hospital, each project will be individually financed through the [Geschickter Fund] as it has been in the past in accordance with previously established procedures and controls using allotted portions of the annual Research and Development budget. The University will be totally unwitting of Agency sponsorship, and the projects to every outward appearance will be sponsored by Dr. [Geschickter].
In the event of Dr. [Geschickter]'s death, the Fund will continue in being and any activities under this project will be continued through the Fund and will be unaffected by his death.
IX. Memorandum of Agreement.
A memorandum of agreement will be signed with Dr. [Geschickter] outlining to the greatest extent possible the arrangements under which the hospital space under his control will be made available to Chemical Division personnel and the manner in which cover will be provided and other benefits obtained. No contract will be signed since Dr. [Geschickter] would be unable to reflect any of the Agency's contractual terms in his arrangements with the University when the [Geschickter Fund] makes the donation in question. The memorandum of agreement will be retained in TSS.
X. Security.
All security matters and details are being co-ordinated with the TSS/Liaison and Security Office.
XI. Resultant Financial Saving.
The $125,000 to be contributed by CIA plus the $125,000 in matching funds provided under P.L. 221 to the Building Fund will be more than offset in a few years by the savings which will result from use of this non-profit fund. If a research project at [Georgetown] University or other educational non-profit institution is sponsored by the U.S. Government, it is customary for the Government to pay for salaries, equipment, supplies, etc. and for overhead as well. In the case of [Georgetown University] the overhead amounts to 80% of salaries. However, if a non-profit foundation such as the [Geschickter Fund] sponsors research at a non-profit institution, the funds granted for the work are customarily used to pay for salaries, equipment and supplies but not for overhead. The Government dollar thus buys considerably more research through the [Geschickter Fund] than would be the case if no cut-out were used.
XII. Legal Matters.
This matter has been discussed with Mr. [Lawrence Houston] of the Office of General Counsel, and he is fully aware of all details surrounding this grant.
[2 pages.]
Downgraded to: CONFIDENTIAL
by authority of: 187475
date: June 1977
E2 IMPDET; CL BY 187475
Copy # 1 of 1 copy
35-5-U
LS 10286
Tab 3
TOP SECRET
21 December 1954
MEMORANDUM FOR: Director of Central Intelligence
SUBJECT: Project MKULTRA, Subproject 35
1. While the Director's statutory authority to expend funds for confidential purposes is not limited by law, we believe that a gift of Government funds as such would exceed the intent of the Congress in granting that power. However, where a gift is made for the express purpose of producing something of value to this Agency which cannot otherwise be obtained and there is a reasonable expectation that the value may be received, the gift may in effect be an expenditure for proper official purposes.
2. In Subproject 35, it is stated that the donation in question would achieve certain ends desired by TSS. There seems to be no question that those ends would be advantageous, so the main questions appear to be whether they could not be attained by more direct, normal methods, and, if not, whether the return is necessary and reasonable in relation to the donation.
3. We are in no position to review the requirements of TSS or to appraise the advantages that would result from the project. We do not comment, therefore, on the value received if the project results in the benefits foreseen. We feel we should comment on factors affecting the probability of achieving those ends. In a legal sense, there is little or no control. Once the funds are donated, the individual, his foundation, or the hospital could conceivably refuse to work for us or allow us use of the facilities.
4. Practically, the control seems to be established as well as circumstances permit. Certainly, as long as the individual is alive and in his present position, we have every reason to expect his complete cooperation in the future as in the past, unless through some act or fault of our own he is alienated. Even in the event of his death or incapacity, there appears to be a reasonable chance of continuing the project. If these probabilities appear sufficient to obtain an adequate return for the expenditure, there can be no legal objection to this aspect of the project.
5. It should be noted that there are two circumstances which require consideration in a final determination. As stated in Section V, our contribution, by appearing to be from a private source, would increase the matching Government contribution by a similar amount which would not be the case if it were known that this was in fact a Government contribution also. Secondly, it is the stated policy of the hospital to charge the Government and commercial organizations 80 per cent overhead on research contracts, whereas nonprofit foundations pay only direct costs but no overhead. Because of the ostensible source, our projects will not be charged overhead. this could be construed as morally wrongful to the hospital, as normally we would pay the 80 per cent overhead charge for projects performed directly for us, but I believe this can be offset, at least to the amount of our donation, and perhaps by the further amount by which the other Government contributions are increased by our donation. In any case, if the project is a proper one and must be performed in this manner, security dictates these circumstances and they, therefore, do not present a legal obstacle as such.
6. We raised the question whether funds for the hospital construction could not be obtained from other normal charitable sources. It appeared that there was a strong possibility that the individual concerned could raise adequate funds from private resources, but it was the position of TSS that if this were the case we would not obtain the commitment from the individual and the degree of control which this project is designed to achieve.
[Signature]
LAWRENCE R. HOUSTON
General Counsel
[Not transcribed: A 4-page draft memorandum, dated 24 January 1955, to Chief/TSS from Sidney Gottlieb, Chief, Chemical Division, TSS, which is similar in content to the memorandum of 15 November 1954 above addressed to the Director of Central Intelligence from Deputy Director (Plans).]
[3 pages.]
Downgraded to: CONFIDENTIAL
by authority of: 187475
date: June 1977
E2 IMPDET; CL BY 187475
35-4-A
TOP SECRET
DRAFT
xxxxxxx
5 May 1955
A portion of the Research and Development Program of TSS/Chemical Division is devoted to the discovery of the following materials and methods:
1. Substances which will promote illogical thinking and impulsiveness to the point where the recipient would be discredited in public.
2. Substances which increase the efficiency of mentation and perception.
3. Materials which will prevent or counteract the intoxicating effect of alcohol.
4. Materials which will promote the intoxicating effect of alcohol.
5. Materials which will produce the signs and symptoms of recognized diseases in a reversible way so that they may be used for malingering, etc.
6. Materials which will render the induction of hypnosis easier or otherwise enhance its usefulness.
7. Substances which will enhance the ability of individuals to withstand privation, torture and coercion during interrogation and so-called "brain-washing".
8. Materials and methods which will produce amnesia for events preceding and during their use.
9. Physical methods of producing shock and confusion over extended periods of time and capable of surreptitious use.
10. Substances which produce physical disablement such as paralysis of the legs, acute anemia, etc.
11. Substances which will produce "pure" euphoria with no subsequent let-down.
12. Substances which alter personality structure in such a way that the tendency of the recipient to become dependent upon another person is enhanced.
13. A material which will cause mental confusion of such a type that the individual under its influence will find it difficult to maintain a fabrication under questioning.
14. Substances which will lower the ambition and general working efficiency of men when administered in undetectable amounts.
15. Substances which promote weakness or distortion of the eyesight or hearing faculties, preferably without permanent effects.
16. A knockout pill which can surreptitiously be administered in drinks, food, cigarettes, as an aerosol, etc., which will be safe to use, provide a maximum of amnesia, and be suitable for use by agent types on an ad hoc basis.
17. A material which can be surreptitiously administered by the above routes and which in very small amounts will make it impossible for a man to perform any physical activity whatsoever.
The development of materials of this type follows the standard practice of such ethical drug houses as xxxxxxxxxxxxxxxxxxxxx. It is a relatively routine procedure to develop a drug to the point of human testing. Ordinarily, the drug houses depend upon the services of private physicians for the final clinical testing. The physicians are willing to assume the responsibility of such tests in order to advance the science of medicine. It is difficult and sometimes impossible for TSS/CD to offer such an inducement with respect to its products. In practice, it has been possible to use outside cleared contractors for the preliminary phases of this work. However, that part which involved human testing at effective dose levels presents security problems which cannot be handled by the ordinary contractor.
The proposed facility xxxxxxxxxxxxx offers a unique opportunity for the secure handling of such clinical testing in addition to the many advantages outline in the project proposal. The security problems mentioned above are eliminated by the fact that the responsibility for the testing will rest completely upon the physician and the hospital. [One line redacted] will allow TSS/CD personnel to supervise the work very closely to make sure that all tests are conducted according to the recognized practices and embody adequate safeguards.
[2 pages.]
Downgraded to: CONFIDENTIAL
by authority of: 187475
date: June 1977
E2 IMPDET; CL BY 187475
35-10
SECRET
AR 7-0211
PRC No. 35/P 250-55
SUBJECT : TSS Research Program, Project MKULTRA, Subproject 35, Amendment #1
PURPOSE: To provide for Agency-sponsored research involving covert biological and chemical warfare.
BACKGROUND:
a. The TSS FY 1955 Operational Program, as approved 26 July 1954 and amended 25 March 1955 provide xxxxxxx dollars initially, plus an additional xxxxxxx by amendment for a current total of xxxxxxx dollars FY 1955 funds for Research and Development.
b. Sub-project 35 of Project MKULTRA was approved by the DCI 15 January 1955 in the amount of $125,000 FY 1955 as part of the approved TSS Program. The proposal was to covertly commit $125,000 as an ostensibly anonymous private contribution toward a 3 million dollar capital expansion (construction) of a non-profit, private, unwitting U.S. medical research facility, currently used covertly by the Agency, in order to indirectly provide required technical research services not otherwise available. An additional contribution of $500,000 from another interested U.S. government Agency was contemplated in this action, but is no longer available.
c. Due to the provisions of Public Law 221, enacted specifically in regard to this Research Facility, sterile contribution of Agency funds, along with other privately raised funds, will be matched by an equal amount of overt U.S. Government funds to be expended in the expansion of the facility. The Office of the General Counsel has raised no legal objection to the principle of sterile Agency contribution in this circumstance.
PROBLEM: The problem, based upon the anticipated value of long-range services we will receive as exceeding the immediate Agency monetary cost, is to replace the withdrawn $500,000 with an equal amount, employing the principle of Public Law 221.
PROPOSAL: It is proposed for purpose of this amendment:
a. to increase the TSS FY 1955 total Program Authorization by $250,000, from xxxxxxxx to xxxxxxxx subject to the availability of funds.
b. in addition to the currently approved contribution of $125,000 FY 1955, to authorize the contribution of an additional $250,000 available to FY 1955 and/or FY 1956, subject to the availability of funds, at the direction of DD/A.
ACTION: After review of the project at the meeting of 11 May 1955, the Committee endorsed the above proposal.
RECOMMENDATION: It is the recommendation of the members of the Committee
that the Director approve the proposal as set forth in this action.
CONCUR:
SIGNED Richard M. Bissell, Jr.
Chairman, PRC
SIGNED xxxxxxxxxxx
Deputy Director (Intelligence)
SIGNED C. P. Cabell
DDCI
SIGNED xxxxxxxxxx
Asst. Deputy Director (Support)
SIGNED Richard Helms
for Deputy Director (Plans)
SIGNED Lyman Kirkpatrick* May 12 1955
Inspector General
APPROVED:
SIGNED A. W. Dulles
Director of Central Intelligence
MAY 16 1955
*With the understanding -- as reached in the PRC meeting -- that TSS and
the General Counsel will work out with the "unwitting U.S. medical research
facility" through an intermediary an agreement to insure a reasonable expectation
of use of the facility in return for the money donated.
Transcription and HTML by Cryptome.